Company Overview and News

 
Sources: Petrobras Pricing Pressure Spooks Potential Refinery Buyers

20h rigzone
SAO PAULO, May 24 (Reuters) - A surprise decision by Brazil's state-controlled oil company Petroleo Brasileiro SA to cut diesel prices in response to truckers' protests is worrying some potential buyers of Petrobras' refineries, three people with knowledge of the matter said on Thursday.

 
Lasalle (LHO) Ends Buyout Battle, Accepts Blackstone's Offer

2018-05-23 zacks
LaSalle Hotel Properties (LHO - Free Report) announced that it has reached a definitive agreement with affiliates of Blackstone Group LP (BX - Free Report) , per which the private equity behemoth will acquire all outstanding common shares of LaSalle for $33.50 per share, in an all-cash deal, valuing the acquisition at $4.8 billion.

 
Deals of the day-Mergers and acquisitions

2018-05-22 reuters
May 22 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1000 GMT on Tuesday:

 
Private Equity Funds Won’t Turn Investors Into Mr. Wonderful

2018-05-22 investorplace
Private equity has long served as a vehicle for outsized returns for the wealthiest investors. These investments do not trade directly on the stock market. They involve private investments in companies with limited transparency to outsiders. They can often involve pre-IPO investments or buyouts that remove companies from a public exchange.

 
LaSalle Hotel Properties Shares Jump on $4.8B Blackstone Buyout

2018-05-21 investorplace
LaSalle Hotel Properties (NYSE:LHO) shares were soaring Monday as the company has agreed to be acquired by private equity firm Blackstone Group LP (NYSE:BX).

 
Macerich: Takeover Target?

2018-05-21 seekingalpha
Predicting takeover targets can be difficult, but MAC has a history of being a takeover target.

1
Are Institutional Investors Bullish on Cheniere Energy Partners?

2018-05-21 marketrealist
Cheniere Energy Partners (CQP), the midstream MLP subsidiary of Cheniere Energy (LNG), saw buying of 0.49 million positions among the top institutional holders during the first quarter.

 
CORRECTED-Data firm IHS Markit to buy Ipreo for $1.86 bln

2018-05-21 reuters
May 21 (Reuters) - Data firm IHS Markit Ltd said on Monday it will buy Ipreo from private equity funds of BlackStone Group LP and Goldman Sachs for $1.86 billion.

 
Michael Gelband to Launch Biggest Hedge Fund Startup Ever - Bloomberg

2018-05-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
LaSalle Hotel accepts Blackstone's US$3.7 billion cash offer

2018-05-21 channelnewsasia
Private equity firm Blackstone Group LP said on Monday it would buy U.S. hotel owner LaSalle Hotel Properties for US$3.7 billion, topping a rival bid from Pebblebrook Hotel Trust for US$3.5 billion.

 
Chicago Fed gauge of national economic activity ticks upward

2018-05-21 feeds.marketwatch
Small-cap stocks are leaving their large-cap peers behind. The outperformance may be just getting started. Full Story

 
Blackstone to buy LaSalle Hotel for US$3.7 billion

2018-05-21 channelnewsasia
Private equity firm Blackstone Group LP said on Monday it would buy U.S. hotel owner LaSalle Hotel Properties for US$3.7 billion, topping a rival bid from Pebblebrook Hotel Trust for US$3.5 billion.

 
Blackstone to buy LaSalle Hotel for $3.7 billion

2018-05-21 reuters
(Reuters) - Private equity firm Blackstone Group LP (BX.N) said on Monday it would buy U.S. hotel owner LaSalle Hotel Properties (LHO.N) for $3.7 billion, topping a rival bid from Pebblebrook Hotel Trust (PEB.N) for $3.5 billion.

 
Data firm IHS Markit to buy rival Ipreo for $1.86 bln

2018-05-21 reuters
(Reuters) - Data firm IHS Markit Ltd (INFO.O) said on Monday it will buy smaller rival Ipreo from private equity funds of BlackStone Group LP (BX.N) and Goldman Sachs (GS.N) for $1.86 billion.

 
Blackstone to Check Out of Hilton Investment - WSJ

2018-05-19 wsj
Blackstone Group LP is shedding its investment in hotel group Hilton Worldwide Holdings Inc., closing out the most profitable private-equity investment in real estate ever.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

22h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

22h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

CUSIP: 09256U105